(Q40749522)

23 September 2017

title

An overview: Antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition (English)

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

leukocyte adherence inhibition test

14 March 2023

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

Immunologic Technique

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

author name string

M. Flores

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

J. H. Marti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

N. Grosser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

J. K. MacFarlane

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

D. M. Thomson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319891

14 March 2023

language of work or name

English

0 references

publication date

1 February 1977

1 reference

full work available at URL

23 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

1 reference

23 September 2017

volume

39

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

494-505

1 reference

Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition Test

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C494%3A%3AAID-CNCR2820390218%3E3.0.CO%3B2-8

Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C494%3A%3AAID-CNCR2820390218%3E3.0.CO%3B2-8

In vitro cellular immunity in mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C494%3A%3AAID-CNCR2820390218%3E3.0.CO%3B2-8

Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C494%3A%3AAID-CNCR2820390218%3E3.0.CO%3B2-8

Antibodies and Soluble Tumour-specific Antigens in Blood and Lymph of Rats with Chemically Induced Sarcomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C494%3A%3AAID-CNCR2820390218%3E3.0.CO%3B2-8

Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C494%3A%3AAID-CNCR2820390218%3E3.0.CO%3B2-8

Effect of autologous mammary tumour extracts on human leukocyte migrationin vitro

21 January 2018

1

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma

14 March 2023

2

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation

14 March 2023

3

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Cellular responses to autologous breast cancer tissue:Correlation with stage and lymphoreticuloendothelial reactive

14 March 2023

4

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

5

36

769

Black

1976

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Sensitization to tumour-associated antigens in human breast carcinoma

14 March 2023

6

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Postoperative Depression of Tumour-directed Cell-mediated Immunity in Patients with Malignant Disease

14 March 2023

7

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

8

50

650

Donnelly

1975

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Cellular immunity to human breast carcinoma

14 March 2023

9

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

11

35

2571

Grosser

1975

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma

14 March 2023

14

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Leukocyte adherence inhibition: a simple test for cell-mediated tumour immunity and serum blocking factors

14 March 2023

15

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Postoperative immunosuppression in patients with breast cancer

14 March 2023

16

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Demonstration of cell-mediated immunity to human neoplasms of various histological types

14 March 2023

17

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Problems Associated With Study of Cell-Mediated Immunity to Human Tumors by Microcytotoxicity Assays

14 March 2023

18

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Antigen-mediated macrophage adherence inhibition

14 March 2023

19

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Protein measurement with the Folin phenol reagent

14 March 2023

22

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Cell-Mediated Immunity and Specific Serum Factors in Human Cancer: The Leukocyte Adherence Inhibition Test2

14 March 2023

23

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma

14 March 2023

27

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Specific responsiveness of leukocytes to soluble extracts of human tumors

14 March 2023

29

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Cellular immunity in mammary cancer patients as measured by the Leukocyte Migration Test (LMT). A follow-up study

14 March 2023

30

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Functional interactions of viral and histocompatibility antigens at tumor cell surfaces

14 March 2023

31

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

32

33

2898

Takasugi

1973

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

Soluble tumour-specific antigen and its relationship to tumour growth

14 March 2023

35

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system

14 March 2023

38

1 reference

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C494::AID-CNCR2820390218%3E3.0.CO;2-8

14 March 2023

Identifiers

10.1002/1097-0142(197702)39:2<494::AID-CNCR2820390218>3.0.CO;2-8

1 reference

23 September 2017

1 reference